GlaxoSmithKline Australia (GSKA) in collaboration with the Asthma CRC is pleased to offer up to two CRC PhD scholars per year a grant of up to $15,000 to work in a GSK laboratory overseas. The travel grant is intended to allow the PhD Scholar the opportunity to develop their skills in a commercial environment and be exposed to procedures and protocols within GSK.

The Scholar will already be the beneficiary of a research grant ("Current Award") from a non commercial source which represents the primary means of support for the Student/Post-doc and will not be employed by a competitive commercial organisation in the healthcare industry.

GlaxoSmithKline is a leading investor in Australian research and development, investing upto $35 million each year-ranking in Australia's top 20 R&D companies. Our global quest is to improve the quality of human life by enabling people to do more, feel better and live longer.